EQUINE PRACTICE - NUTRITION
Reprinted with permission of publisher
Effect of a Nutritional Supplement Containing
N,N-Dimethylglycine (DMG)
on the Racing Standardbred
Steve B. Levine, D.V.M.; Grant
D. Myhre, D.V.M.; Guy L. Smith, D.V.M.; James G. Burns,
D.V.M.
Rochester Equine Clinic, P.O. Box 2113, Ten Rod Road,
Rochester, New Hampshire 03867
Hollis Erb, D.V.M., Ph.D.
Department of Preventive Medicine, N.Y. State College
of Veterinary Medicine, Cornell University, Ithaca,
New York 14853
The effects of including a nutritional supplement containing
N,N-Dimethylglycine (DMG), Spur-15® (Spur-DMG) in
the diet of 10 racing Standardbreds are discussed. Results
of this study indicate that Spur-15 is responsible
for a lower blood lactic acid level following training.
Horses were found to be more "aggressive", to
have better appetites and attitudes and to recover faster
from racing and training than the control group studied.
Tables are included.
Introduction
A project was carried out to observe the effects
of a nutritional supplement containing N,N-Dimethylglycine
(DMG), (Spur-15® : United States Animal Laboratories,
marketed as Spur-DMG) on certain blood parameters and
performances of the racing Standardbred. Previous research
has shown that DMG can increase oxygen utilization and
thereby decrease lactic acid levels in animals under extreme
stress.1 Using human subjects, research conducted
at the Institute of Human Fitness in Escondido, California
revealed a 27.6% increase in exhaustion time in trained
athletes in treadmill tests, when compared with a placebo.2
DMG has further been shown to enhance the body's immune
response, both by increasing antibody production and lymphocyte
generation.3 Our experiment was designed to
view the effects of this supplement on certain objective
and subjective parameters in the Standardbred race horse.
Materials and Methods
Twenty racing Standardbreds, aged 3 to 8 years
(7 stallions, 8 geldings, 5 mares), were used in this
project. They were randomly divided into a control group
and an equal group to receive the Spur-15. Blood samples
were drawn on all horses the morning that supplementation
was to begin. The test group then began to receive the
Spur-15 twice daily in the normal grain ration. Rations
were identical except for the Spur-15. Blood tests were
taken on all horses the following day, after a training
session. Two weeks later blood samples were again taken
on the group receiving Spur-15. The next day these horses
were again tested following training. On Day 34 of the
protocol all horses were again tested and then tested
the following morning after training. The horses in the
experimental group received 1.5 packets of Spur-15 twice
daily in their grain throughout the project. All the horses
were raced and trained normally through this experiment.
Complete blood counts were done on all blood samples,
as well as creatinine phosphokinase, lactic acid, calcium,
cholesterol, glucose, BUN, uric acid, creatinine, total
bilirubin, alkaline phosphatase, LDH and SGOT. At the
end of the protocol, the trainers were asked for subjective
evaluations of their horses condition in terms of racing
fitness, attitude, general health and recovery from illness
or injury.
Results
Lactic acid levels were of greatest interest
in this project. As earlier stated, DMG has been shown
experimentally to reduce lactic acid levels in animals
and man under stress. Inspection of all data revealed
no significant differences between control and treatment
horses except for lactic acid levels. Results of lactic
acid determinations following training (i.e., Day 2 and
35) were significantly lower (P > 0.022 and 0.062 respectively)
in the treatment groups than in the controls (Table 1).
| TABLE
1
Results of Lactic Acid Determinations
(Meq/l) |
| Day |
Treatment |
Control |
| 1 |
0.27" 0.14 |
0.33" 0.09 |
| 2 |
0.45" 0.18 |
3.51" 4.23 |
| 15 |
0.53" 0.16 |
|
| 16 |
0.68" 0.17 |
|
| 34 |
0.45" 0.16 |
0.36" 0.12 |
| 35 |
0.52" 0.23 |
2.64" 2.88 |
Discussion
Spur-15 is a nutritional supplement comprised
of an equimolar mixture of N,N-Dimethylglycine (DMG) and
calcium gluconate, Vitamin A, Vitamin E, Vitamin D, iron-proteinate,
copper gluconate and manganese ascorbate in an alfalfa
base. The concentration of each ingredient per package
is shown in Table 2.
|
Table 2
Spur-15 (Spur-DMG) Packet Contents
|
| N,N-Dimethylglycine |
400 mg
|
| Calcium Gluconate |
600 mg |
| Vitamin A (Fish Liver
Oil) |
25,000 IU |
| Vitamin E (D-Alpha
Tocopherol Succinate) |
500 IU |
| Vitamin D3
(Cholecalciferol) |
250 IU |
| Iron (Proteinate) |
5 mg |
| Copper (Gluconate)
|
1.5 mg |
| Manganese (Ascorbate)
|
5 mg |
DMG is an accessory food factor now generally known as
a biologically active non-fuel nutrient. There are two
groups of these nonfuel nutrients; vitamins and metabolic
enhancers, of which DMG is a member. This group contains
intermediary metabolites of endogenous origin. They are
synthesized in vivo and appear to be necessary
to maintain the organism's optimum performance or "health."
Included in this group of metabolic enhancers are:
- intermediary nitrogen containing metabolites (ie.,
DMG, choline, glycine and adenosine),
- sterols,
- intermediary metabolites of carbohydrate origin,
- proteins and peptides.
The identification of DMG is recent (1977) and many mammalian
enzyme systems have already been shown to utilize or produce
it. The metabolic role of DMG in these reactions is as
a supplier of one-carbon units.
The results of this trial indicate that Spur-15, included
in the diet of the racing Standardbred, is responsible
for a lower blood lactic acid level following training.
On a subjective level these horses were found by their
trainers to be more"aggressive", to have better
appetites and attitudes and to recover faster from racing
and training than the controls.
REFERENCES
1. Meduski JW, Meduski JD, Hymen S, Kily A,
Kim S, Thein A, Yoshimoto R: Decrease of Lactic Acid
Concentration in Blood of Animals Given N,N-Dimethylglycine.
Presented at 1980 Pacific Slope Biochemical Conference.
July 7-9, 1980. University of California, San Diego.
2. Barnes L.: B15: The Politics of ergogenicity.
The Physician and Sports Medicine 7(11).
Nov. 1979.
3. Graber CD, Goust JM, Glassman AD, Kendsll R, Woodholl
CB: Immunomodulaling Properties of Dimethylglycine
in Humans. The Journal of Infectious Diseases
143(1), Jan. 1981.
|